• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院老年患者静脉血栓栓塞症预防用药的模式和结局:一项回顾性队列研究。

Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study.

机构信息

Division of Hospital Medicine, Department of Medicine, Northwell Health, Manhasset, NY, 11030, USA.

Division of Hospital Medicine, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Manhasset, NY, 11030, USA.

出版信息

J Thromb Thrombolysis. 2018 Apr;45(3):369-376. doi: 10.1007/s11239-018-1611-8.

DOI:10.1007/s11239-018-1611-8
PMID:29330739
Abstract

Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the United States. Hospitalized, medically ill older adults have increased risk; despite guidelines, data suggest suboptimal pharmacologic prophylaxis rates. Factors influencing provider prescribing non-compliance are unclear. We aimed to describe VTE prophylaxis practices and identify risk factors for, and outcomes of, prescribing non-compliance. A retrospective study was conducted of hospitalized adults aged ≥ 75 years, admitted to the medicine service of a large academic tertiary center from May 1, 2014 to June 30, 2015. The primary outcome was non-compliance, defined as the absence of an order for VTE prophylaxis for the duration of hospitalization or an interruption of prophylaxis exceeding 24 h. Secondary measures included in-hospital mortality, length of stay (LOS), and 30-day readmissions. Of 3751 patients (mean age 84.7 years), 97.6% of charts had prophylaxis orders; 11.0% showed non-compliance. Pharmacologic prophylaxis was prescribed in 83.3% of patients and mechanical prophylaxis alone in 14.3%. Factors associated with non-compliance included: higher body mass index (BMI) (p = 0.04), myocardial infarction (p = 0.01), congestive heart failure (p = 0.001), metastatic tumor (p = 0.01). Low mobility was not significantly associated with compliance. Subcutaneous unfractionated heparin was associated with compliance (p < 0.0001); warfarin (p < 0.0001), heparin infusion (p < 0.0001) and low-molecular-weight heparin (p < 0.0001) with non-compliance. Non-compliance was associated with increased mortality (p = 0.01), LOS (p < 0.0001), readmissions (p = 0.0004). Known VTE risk factors (mobility, BMI, comorbidities) were not associated with prescriber compliance patterns. Integrating risk assessment models into provider practice may improve compliance.

摘要

静脉血栓栓塞症(VTE)是美国发病率和死亡率的主要原因。住院和患有内科疾病的老年人风险增加;尽管有指南,但数据表明药物预防率不理想。影响提供者处方不遵守的因素尚不清楚。我们旨在描述 VTE 预防措施,并确定处方不遵守的风险因素以及结果。对 2014 年 5 月 1 日至 2015 年 6 月 30 日期间在一家大型学术三级中心内科病房住院的年龄≥75 岁的成年人进行了回顾性研究。主要结果是不遵守,定义为在住院期间没有开具 VTE 预防药物或预防措施中断超过 24 小时。次要措施包括院内死亡率、住院时间(LOS)和 30 天再入院。在 3751 名患者中(平均年龄 84.7 岁),97.6%的病历中有预防措施医嘱;11.0%的患者不遵守。83.3%的患者开具了药物预防措施,14.3%的患者仅开具了机械预防措施。与不遵守相关的因素包括:更高的体重指数(BMI)(p=0.04)、心肌梗死(p=0.01)、充血性心力衰竭(p=0.001)、转移性肿瘤(p=0.01)。低活动度与合规性无显著相关性。皮下未分级肝素与合规性相关(p<0.0001);华法林(p<0.0001)、肝素输注(p<0.0001)和低分子肝素(p<0.0001)与不遵守相关。不遵守与死亡率增加(p=0.01)、住院时间延长(p<0.0001)和再入院相关(p=0.0004)。已知的 VTE 风险因素(活动度、BMI、合并症)与处方者的依从模式无关。将风险评估模型纳入提供者的实践中可能会提高依从性。

相似文献

1
Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study.住院老年患者静脉血栓栓塞症预防用药的模式和结局:一项回顾性队列研究。
J Thromb Thrombolysis. 2018 Apr;45(3):369-376. doi: 10.1007/s11239-018-1611-8.
2
Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.心力衰竭住院老年患者的静脉血栓栓塞症药物预防和 30 天结局:来自 ADHERE 国家登记处与医疗保险索赔链接的分析。
Clin Cardiol. 2011 Nov;34(11):682-8. doi: 10.1002/clc.20986. Epub 2011 Nov 6.
3
Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma.使用强制性计算机化临床决策支持工具预防创伤患者静脉血栓栓塞,预防措施得到改进,可预防伤害的发生率降低。
Arch Surg. 2012 Oct;147(10):901-7. doi: 10.1001/archsurg.2012.2024.
4
Prophylaxis against venous thromboembolism in hospitalized medically ill patients.住院内科疾病患者静脉血栓栓塞的预防
Circ Cardiovasc Qual Outcomes. 2013 Jan 1;6(1):75-82. doi: 10.1161/CIRCOUTCOMES.112.965939. Epub 2013 Jan 8.
5
Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.活动性溃疡性结肠炎住院患者药物性静脉血栓栓塞预防率:来自一家三级护理中心的结果。
J Crohns Colitis. 2013 Dec;7(12):e635-40. doi: 10.1016/j.crohns.2013.05.002. Epub 2013 May 22.
6
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).风险评估模型(Padua 预测评分和改善出血评分)在静脉血栓栓塞症、大出血和与药物预防 VTE 相关的卫生支出方面的临床影响:一项在单个内科病房住院患者中进行的“真实生活”前瞻性和回顾性观察研究(STIME 研究)。
Intern Emerg Med. 2018 Jun;13(4):527-534. doi: 10.1007/s11739-018-1808-z. Epub 2018 Mar 3.
7
Defects in Processes of Care for Pharmacologic Prophylaxis Are Common Among Neurosurgery Patients Who Develop In-Hospital Postoperative Venous Thromboembolism.神经外科术后发生医院内静脉血栓栓塞症的患者,其药物预防的护理流程缺陷很常见。
World Neurosurg. 2020 Feb;134:e664-e671. doi: 10.1016/j.wneu.2019.10.163. Epub 2019 Nov 4.
8
Venous thromboembolism prophylaxis in hospitalized heart failure patients.住院心力衰竭患者的静脉血栓栓塞预防
J Card Fail. 2008 Mar;14(2):127-32. doi: 10.1016/j.cardfail.2007.10.017.
9
An Electronic Alert System Is Associated With a Significant Increase in Pharmacologic Venous Thromboembolism Prophylaxis Rates Among Hospitalized Inflammatory Bowel Disease Patients.电子警报系统与住院炎症性肠病患者药物性静脉血栓栓塞预防率的显著提高相关。
J Healthc Qual. 2017 Sep/Oct;39(5):307-314. doi: 10.1097/JHQ.0000000000000021.
10
Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events.静脉血栓栓塞症预防“智能医嘱集”的影响:提高了依从性,减少了事件。
Am J Hematol. 2013 Jul;88(7):545-9. doi: 10.1002/ajh.23450. Epub 2013 Jun 12.

引用本文的文献

1
Risk Factors for Early Hospital Readmission in Geriatric Patients: A Systematic Review.老年患者早期住院再入院的危险因素:系统评价。
Int J Environ Res Public Health. 2023 Jan 17;20(3):1674. doi: 10.3390/ijerph20031674.
2
Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort.行动不便的老年住院患者中药物性血栓预防措施的使用不足:SWITCO65+队列研究
Res Pract Thromb Haemost. 2020 Nov 6;5(1):142-147. doi: 10.1002/rth2.12361. eCollection 2021 Jan.

本文引用的文献

1
Implementing ACOVE Quality Indicators as an Intervention Checklist to Improve Care for Hospitalized Older Adults.将ACOVE质量指标作为干预检查表来实施,以改善对住院老年人的护理。
J Hosp Med. 2017 Jul;12(7):517-522. doi: 10.12788/jhm.2765.
2
The epidemiology of venous thromboembolism.静脉血栓栓塞症的流行病学
J Thromb Thrombolysis. 2016 Jan;41(1):3-14. doi: 10.1007/s11239-015-1311-6.
3
Adherence to mechanical thromboprophylaxis after surgery: A systematic review and meta-analysis.术后机械性血栓预防的依从性:系统评价和荟萃分析。
Thromb Res. 2015 Oct;136(4):723-6. doi: 10.1016/j.thromres.2015.06.023. Epub 2015 Jun 21.
4
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.非外科患者的 VTE 预防:抗血栓治疗和血栓预防,第 9 版:美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e195S-e226S. doi: 10.1378/chest.11-2296.
5
Low-molecular-weight heparin and mortality in acutely ill medical patients.低分子肝素与急症医疗患者的死亡率。
N Engl J Med. 2011 Dec 29;365(26):2463-72. doi: 10.1056/NEJMoa1111288.
6
Predictive and associative models to identify hospitalized medical patients at risk for VTE.预测和关联模型,以识别住院医疗患者中 VTE 风险患者。
Chest. 2011 Sep;140(3):706-714. doi: 10.1378/chest.10-1944. Epub 2011 Mar 24.
7
Prevalence of clinical venous thromboembolism in the USA: current trends and future projections.美国临床静脉血栓栓塞症的流行情况:当前趋势和未来预测。
Am J Hematol. 2011 Feb;86(2):217-20. doi: 10.1002/ajh.21917.
8
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.一种用于识别住院医疗患者静脉血栓栓塞风险的风险评估模型:帕多瓦预测评分。
J Thromb Haemost. 2010 Nov;8(11):2450-7. doi: 10.1111/j.1538-7836.2010.04044.x.
9
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.急性医院护理环境中的静脉血栓栓塞风险与预防(ENDORSE研究):一项跨国横断面研究。
Lancet. 2008 Feb 2;371(9610):387-94. doi: 10.1016/S0140-6736(08)60202-0.
10
Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.荟萃分析:住院内科患者预防性使用抗凝剂预防有症状静脉血栓栓塞症
Ann Intern Med. 2007 Feb 20;146(4):278-88. doi: 10.7326/0003-4819-146-4-200702200-00007.